LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2)
Status:
Recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
This is a randomized controlled trial to evaluate the use of LASER, Micro Ablative
radiofrequency and topic promestriene to treat symptoms of vulvovaginal atrophy of women
treated for breast cancer.
Phase:
N/A
Details
Lead Sponsor:
Federal University of São Paulo
Collaborator:
Fundação de Amparo à Pesquisa do Estado de São Paulo